RESUMO
The HIV-1 capsid (CA) utilizes CPSF6 for nuclear entry and integration site targeting. Previous studies demonstrated that the HIV-1 CA C-terminal domain (CTD) contains a highly conserved K182 residue involved in interaction with CPSF6. In contrast, certain HIV-2 strains possess a substitution at this residue (K182R). To assess whether CA-CPSF6 interaction via the CA CTD is conserved among primate lentiviruses, we examined resistance of several HIV-1- and HIV-2-lineage viruses to a truncated form of CPSF6, CPSF6-358. The results demonstrated that viruses belonging to the HIV-2-lineage maintain interaction with CPSF6 regardless of the presence of the K182R substitution, in contrast to the case with HIV-1-lineage viruses. Our structure-guided mutagenesis indicated that the differential requirement for CA-CPSF6 interaction is regulated in part by residues near the 182nd amino acid of CA. These results demonstrate a previously unrecognized distinction between HIV-1 and HIV-2, which may reflect differences in their evolutionary histories.
Assuntos
Capsídeo/metabolismo , HIV-1/genética , HIV-2/genética , Fatores de Poliadenilação e Clivagem de mRNA/química , Sequência de Aminoácidos , Substituição de Aminoácidos , Sítios de Ligação , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD4-Positivos/virologia , Capsídeo/ultraestrutura , Linhagem Celular , Núcleo Celular/metabolismo , Núcleo Celular/virologia , Expressão Gênica , Regulação da Expressão Gênica , Células HEK293 , HIV-1/crescimento & desenvolvimento , HIV-1/metabolismo , HIV-2/crescimento & desenvolvimento , HIV-2/metabolismo , Interações Hospedeiro-Patógeno , Humanos , Modelos Moleculares , Ligação Proteica , Conformação Proteica em alfa-Hélice , Conformação Proteica em Folha beta , Domínios e Motivos de Interação entre Proteínas , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Especificidade da Espécie , Replicação Viral , Fatores de Poliadenilação e Clivagem de mRNA/genética , Fatores de Poliadenilação e Clivagem de mRNA/metabolismoRESUMO
Animal cells have multiple innate effector mechanisms that inhibit viral replication. For the pathogenic retrovirus human immunodeficiency virus 1 (HIV-1), there are widely expressed restriction factors, such as APOBEC3 proteins, tetherin/BST2, SAMHD1 and MX2, as well as TRIM5α. We previously found that the TRIM5α gene clearly affects SIVmac or HIV-2 replication, but the major determinant of the combinatorial effect caused by multiple host restriction factors is still not fully clear. APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G), a host restriction factor that restricts HIV replication by causing cytosine deamination, can be targeted and degraded by the SIV/HIV-1/HIV-2 accessory protein Vif. Although rhesus macaques are widely used in HIV/AIDS research, little is known regarding the impact of APOBEC3G gene polymorphisms on viral Vif-mediated ubiquitin degradation in Chinese-origin rhesus macaques. In this study, we therefore genotyped APOBEC3G in 35 Chinese rhesus macaques. We identified a novel transcript and 27 APOBEC3G polymorphisms, including 20 non-synonymous variants and 7 synonymous mutation sites, of which 10 were novel. According to the predicted structure of the A3G protein, we predicted that the E88K and G212D mutations, both on the surface of the A3G protein, would have a significant effect on Vif-induced A3G degradation. However, an in vitro overexpression assay showed that these mutations did not influence HIV-2-Vif-mediated degradation of APOBEC3G. Unexpectedly, another polymorphism L71R, conferred resistance to Vif-mediated ubiquitin degradation, strongly suggesting that L71R might play an important role in antiviral defense mechanisms.
Assuntos
Desaminase APOBEC-3G/genética , Desaminase APOBEC-3G/metabolismo , HIV-2/genética , Replicação Viral/genética , Produtos do Gene vif do Vírus da Imunodeficiência Humana/metabolismo , Sequência de Aminoácidos , Animais , Linhagem Celular , China , Citosina Desaminase/genética , Células HEK293 , HIV-2/crescimento & desenvolvimento , Humanos , Macaca mulatta , Polimorfismo Genético/genética , Alinhamento de Sequência , UbiquitinaçãoRESUMO
How SIV progenitors evolved into deadly HIV-1 and HIV-2 following initial cross-species transmission still remains a mystery. Here, we used humanized mice as a human surrogate system to evaluate SIVsm evolution into HIV-2. Increased viral virulence to human CD4+ T cells and adaptive genetic changes were observed during serial passages.
Assuntos
Cercocebus atys/virologia , Modelos Animais de Doenças , HIV-2/crescimento & desenvolvimento , HIV-2/genética , Animais , Humanos , Camundongos , Inoculações Seriadas , Vírus da Imunodeficiência Símia , Carga ViralRESUMO
HIV-2 is thought to have originated from an SIV progenitor native to sooty mangabeys. To model the initial human transmission and understand the sequential viral evolution, humanized mice were infected with SIVsm and serially passaged for five generations. Productive infection was seen by week 3 during the initial challenge followed by chronic viremia and gradual CD4+ T cell decline. Viral loads increased by the 5th generation resulting in more rapid CD4+ T cell decline. Genetic analysis revealed several amino acid substitutions that were nonsynonymous and fixed in multiple hu-mice across each of the 5 generations in the nef, env and rev regions. The highest rate of substitution occurred in the nef and env regions and most were observed within the first two generations. These data demonstrated the utility of hu-mice in modeling the SIVsm transmission to the human and to evaluate its potential sequential evolution into a human pathogen of HIV-2 lineage.
Assuntos
Cercocebus atys/virologia , Evolução Molecular , HIV-2/crescimento & desenvolvimento , HIV-2/genética , Vírus da Imunodeficiência Símia/crescimento & desenvolvimento , Vírus da Imunodeficiência Símia/genética , Substituição de Aminoácidos , Animais , Contagem de Linfócito CD4 , Humanos , Camundongos , Camundongos SCID , Modelos Biológicos , Inoculações Seriadas , Carga Viral , Proteínas Virais/genéticaRESUMO
Human immunodeficiency virus 2 Vpx coordinates zinc through residues H39, H82, C87 and C89. We reported previously that H39, H82 and C87 mutants maintain Vpx activity to facilitate the degradation of SAMHD1. Herein, the expression of Vpx mutants in cells was examined in detail. We demonstrated that the zinc-binding site stabilizes the protein to keep its function in virus growth when low levels of Vpx are expressed. At higher levels of expression, Vpx aggregation could occur, and zinc binding would suppress such aggregation. Among the amino acids involved in zinc coordination, H39 plays the most critical role. In summary, zinc binding appears to mitigate flexibility of the three-helix fold of Vpx, thereby preventing dysfunction.
Assuntos
HIV-2/metabolismo , Proteínas Virais Reguladoras e Acessórias/química , Zinco/química , Sítios de Ligação/genética , Células HEK293 , HIV-2/crescimento & desenvolvimento , Humanos , Mutação , Dobramento de Proteína , Estabilidade Proteica , Proteínas Virais Reguladoras e Acessórias/genéticaRESUMO
Because of the difficulty of obtaining Indian-origin rhesus macaques, Chinese-origin rhesus macaques (CR) and Vietnamese-origin cynomolgus macaques (CM) are now used frequently in HIV/AIDS research. Nonetheless, the effects of TRIM5α polymorphism on viral replication in both CR and CM are unclear. To address these questions, we recruited 70 unrelated CR and 40 unrelated CM and studied the effect of TRIM5α polymorphism on HIV-2ROD and SIVmac239 replication in PBMCs. We found that 3 polymorphisms, located in the B30.2 domain of CR TRIM5α formed a haplotype and affected HIV-2ROD replication. In addition, we found that the variant Y178H, located in the Coiled-coil domain of CM TRIM5α, affected TRIM5α-mediated HIV-2ROD restriction. Finally, two polymorphisms, located in the Coiled-coil domain, altered anti-SIVmac239 activity in CR. We concluded that, CM TRIM5α polymorphism could alter HIV-2ROD infection; however, a different domain of CR TRIM5α was responsible for restricting different virus replication.
Assuntos
Proteínas de Transporte/genética , HIV-2/crescimento & desenvolvimento , Leucócitos Mononucleares/virologia , Vírus da Imunodeficiência Símia/crescimento & desenvolvimento , Dedos de Zinco/genética , Animais , China , Modelos Animais de Doenças , Genótipo , Macaca fascicularis , Macaca mulatta , Doenças dos Macacos/virologia , Polimorfismo de Nucleotídeo Único/genética , Vietnã , Replicação ViralRESUMO
Retroviruses are among the best studied viruses in last decades due to their pivotal involvement in cellular processes and, most importantly, in causing human diseases, most notably-acquired immunodeficiency syndrome (AIDS) that is triggered by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2, respectively). Numerous studied were conducted to understand the involvement of the three cardinal retroviral enzymes, reverse transcriptase, integrase and protease, in the life cycle of the viruses. These studies have led to the development of many inhibitors of these enzymes as anti-retroviral specific drugs that are used for routine treatments of HIV/AIDS patients. Interestingly, a fourth virus-encoded enzyme, the deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) is also found in several major retroviral groups. The presence and the importance of this enzyme to the life cycle of retroviruses were usually overlooked by most retrovirologists, although the occurrence of dUTPases, particularly in beta-retroviruses and in non-primate retroviruses, is known for more than 20 years. Only more recently, retroviral dUTPases were brought into the limelight and were shown in several cases to be essential for viral replication. Therefore, it is likely that future studies on this enzyme will advance our knowledge to a level that will allow designing novel, specific and potent anti-dUTPase drugs that are effective in combating retroviral diseases. The aim of this review is to give concise background information on dUTPases in general and to summarize the most relevant data on retroviral dUTPases and their involvement in the replication processes and pathogenicity of the viruses, as well as in possibly-associated human diseases.
Assuntos
Pirofosfatases/genética , Pirofosfatases/metabolismo , Retroviridae/enzimologia , Replicação Viral , Animais , Infecções por HIV/virologia , HIV-1/enzimologia , HIV-1/crescimento & desenvolvimento , HIV-1/patogenicidade , HIV-2/enzimologia , HIV-2/crescimento & desenvolvimento , HIV-2/patogenicidade , Humanos , Filogenia , Retroviridae/classificação , Retroviridae/patogenicidade , Retroviridae/fisiologia , Alinhamento de SequênciaRESUMO
BACKGROUND: Human immunodeficiency virus 1 and 2 (HIV-1 and HIV-2) use cellular receptors in distinct ways. Besides a more promiscuous usage of coreceptors by HIV-2 and a more frequent detection of CD4-independent HIV-2 isolates, we have previously identified two HIV-2 isolates (HIV-2MIC97 and HIV-2MJC97) that do not use the two major HIV coreceptors: CCR5 and CXCR4. All these features suggest that in HIV-2 the Env glycoprotein subunits may have a different structural organization enabling distinct - although probably less efficient - interactions with cellular receptors. RESULTS: By infectivity assays using GHOST cell line expressing CD4 and CCR8 and blocking experiments using CCR8-specific ligand, I-309, we show that efficient replication of HIV-2MIC97 and HIV-2MJC97 requires the presence of CCR8 at plasma cell membrane. Additionally, we disclosed the determinants of chemokine receptor usage at the molecular level, and deciphered the amino acids involved in the usage of CCR8 (R8 phenotype) and in the switch from CCR8 to CCR5 or to CCR5/CXCR4 usage (R5 or R5X4 phenotype). The data obtained from site-directed mutagenesis clearly indicates that the main genetic determinants of coreceptor tropism are located within the V1/V2 region of Env surface glycoprotein of these two viruses. CONCLUSIONS: We conclude that a viral population able to use CCR8 and unable to infect CCR5 or CXCR4-positive cells, may exist in some HIV-2 infected individuals during an undefined time period, in the course of the asymptomatic stage of infection. This suggests that in vivo alternate molecules might contribute to HIV infection of natural target cells, at least under certain circumstances. Furthermore we provide direct and unequivocal evidence that the usage of CCR8 and the switch from R8 to R5 or R5X4 phenotype is determined by amino acids located in the base and tip of V1 and V2 loops of HIV-2 Env surface glycoprotein.
Assuntos
Aminoácidos/metabolismo , HIV-2/fisiologia , Receptores CCR5/metabolismo , Receptores CCR8/metabolismo , Receptores CXCR4/metabolismo , Ligação Viral , Produtos do Gene env do Vírus da Imunodeficiência Humana/metabolismo , Adulto , Aminoácidos/genética , Linhagem Celular , Análise Mutacional de DNA , HIV-2/genética , HIV-2/crescimento & desenvolvimento , Humanos , Mutagênese Sítio-Dirigida , Receptores de HIV/metabolismo , Replicação Viral , Produtos do Gene env do Vírus da Imunodeficiência Humana/genéticaRESUMO
The synthesis and the assessment of the anti-HIV activity of a set of molecules inspired by the multivalent structures of some naturally-occurring polyphenols (tannins) are reported. Different multibranched scaffolds have been derived from pentaerythritol as the central core which distribute spatially synthetic polyphenolic subunits based on 1-substituted 2,3,4-trihydroxyphenyl moieties. A tetrapodal compound () bearing four N-(2,3,4-trihydroxyphenyl)amide groups, exhibits remarkable selective activity against HIV-1 with EC50 values in the micromolar scale, in the same range as those reported for the most representative anti-HIV tannins. Preliminary SAR studies emphasize the importance of the 1-substituted 2,3,4-trihydroxyphenyl moiety, the presence of an amide as the linker and the multivalent architecture of these molecules, since the anti-HIV activity increases with the number of polyphenolic moieties. The data support the interest in synthetic polyphenols and represent a promising starting point for further design and development of selective HIV-1 inhibitors.
Assuntos
Fármacos Anti-HIV/síntese química , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Polifenóis/síntese química , Propilenoglicóis/química , Taninos/química , Fármacos Anti-HIV/química , Fármacos Anti-HIV/farmacologia , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/patologia , Linfócitos T CD4-Positivos/virologia , Linhagem Celular , Desenho de Fármacos , HIV-1/crescimento & desenvolvimento , HIV-2/crescimento & desenvolvimento , Humanos , Concentração Inibidora 50 , Modelos Moleculares , Polifenóis/química , Polifenóis/farmacologia , Relação Estrutura-AtividadeRESUMO
A series of new methyl [2-(arylmethylene-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates (5a-o) were synthesized via cyclocondensation of thiosemicarbazones (3a-o) with dimethyl but-2-ynedioate (4) in good yields under solvent-free conditions. The environmentally friendly solvent-free protocol overcomes the limitations associated with the customary protracted solution phase synthesis and afforded the title compounds in a few minutes. Compounds 5b-i and 5h-o were evaluated for their antiviral activity against the replication activity of HIV-1 and HIV-2 in MT-4 using the MTT assay. The same compounds were also evaluated in vitro for their selective antiviral activity against hepatitis C virus (HCV) in the Huh 5-2 replicon system (type 1b, Con1 strain).
Assuntos
Acetatos/síntese química , Acetatos/farmacologia , Antivirais/síntese química , Antivirais/farmacologia , Desenho de Fármacos , Tiazolidinas/síntese química , Tiazolidinas/farmacologia , Fármacos Anti-HIV/síntese química , Fármacos Anti-HIV/farmacologia , Linhagem Celular Tumoral , HIV-1/efeitos dos fármacos , HIV-1/crescimento & desenvolvimento , HIV-2/efeitos dos fármacos , HIV-2/crescimento & desenvolvimento , Hepacivirus/efeitos dos fármacos , Hepacivirus/crescimento & desenvolvimento , Humanos , Estrutura Molecular , Relação Estrutura-Atividade , Replicação Viral/efeitos dos fármacosRESUMO
Described in this unit are basic protocols frequently used in the research of human immunodeficiency viruses (HIVs). Provided are methods for propagating and quantifying HIV, as well as recommendations for long-term storage. Background information about these methods is also provided and includes their advantages, disadvantages, and troubleshooting.
Assuntos
HIV-1/crescimento & desenvolvimento , HIV-1/isolamento & purificação , HIV-2/crescimento & desenvolvimento , HIV-2/isolamento & purificação , Preservação Biológica/métodos , Carga Viral , Linhagem Celular , Humanos , Cultura de Vírus/métodosRESUMO
BST-2/CD317/HM1.24/tetherin is a B-cell antigen overexpressed on the surface of myeloma cell lines and on neoplastic plasma cells of patients with multiple myeloma. Antibodies to BST-2 are in clinical trial for the treatment of multiple myeloma and are considered for the treatment of solid tumors with high BST-2 antigen levels. Functionally, BST-2 restricts the secretion of retroviruses, including human immunodeficiency virus type 1, as well as members of the herpesvirus, filovirus, and arenavirus families, presumably by tethering nascent virions to the cell surface. Here we report that BST-2 antibody treatment facilitates virus release from BST-2(+) cells by interfering with the tethering activity of BST-2. BST-2 antibodies were unable to release already tethered virions and were most effective when added early during virus production. BST-2 antibody treatment did not affect BST-2 dimerization and did not reduce the cell surface expression of BST-2. Interestingly, BST-2 antibody treatment reduced the nonspecific shedding of BST-2 and limited the encapsidation of BST-2 into virions. Finally, flotation analyses indicate that BST-2 antibodies affect the distribution of BST-2 within membrane rafts. Our data suggest that BST-2 antibody treatment may enhance virus release by inducing a redistribution of BST-2 at the cell surface, thus preventing it from accumulating at the sites of virus budding.
Assuntos
Anticorpos/metabolismo , Antígenos CD/imunologia , HIV-1/fisiologia , HIV-2/fisiologia , Liberação de Vírus , Linhagem Celular , Proteínas Ligadas por GPI/antagonistas & inibidores , Proteínas Ligadas por GPI/imunologia , HIV-1/crescimento & desenvolvimento , HIV-2/crescimento & desenvolvimento , HumanosRESUMO
We previously reported that human immunodeficiency virus type 2 (HIV-2) carrying alanine or glutamine but not proline at position 120 of the capsid protein (CA) could grow in the presence of anti-viral factor TRIM5α of cynomolgus monkey (CM). To elucidate details of the interaction between the CA and TRIM5α, we generated mutant HIV-2 viruses, each carrying one of the remaining 17 possible amino acid residues, and examined their sensitivity to CM TRIM5α-mediated restriction. Results showed that hydrophobic residues or those with ring structures were associated with sensitivity, while those with small side chains or amide groups conferred resistance. Molecular dynamics simulation study revealed a structural basis for the differential TRIM5α sensitivities. The mutations at position 120 in the loop between helices 6 and 7 (L6/7) affected conformation of the neighboring loop between helices 4 and 5 (L4/5), and sensitive viruses had a common L4/5 conformation. In addition, the common L4/5 structures of the sensitive viruses were associated with a decreased probability of hydrogen bond formation between the 97th aspartic acid in L4/5 and the 119th arginine in L6/7. When we introduced aspartic acid-to-alanine substitution at position 97 (D97A) of the resistant virus carrying glutamine at position 120 to disrupt hydrogen bond formation, the resultant virus became moderately sensitive. Interestingly, the virus carrying glutamic acid at position 120 showed resistance, while its predicted L4/5 conformation was similar to those of sensitive viruses. The D97A substitution failed to alter the resistance of this particular virus, indicating that the 120th amino acid residue itself is also involved in sensitivity regardless of the L4/5 conformation. These results suggested that a hydrogen bond between the L4/5 and L6/7 modulates the overall structure of the exposed surface of the CA, but the amino acid residue at position 120 is also directly involved in CM TRIM5α recognition.
Assuntos
Proteínas do Capsídeo/genética , HIV-2/genética , Proteínas/química , Proteínas/imunologia , Vírus da Imunodeficiência Símia/genética , Substituição de Aminoácidos , Animais , Western Blotting , Proteínas do Capsídeo/metabolismo , Infecções por HIV/genética , Infecções por HIV/imunologia , Infecções por HIV/virologia , HIV-1/genética , HIV-1/imunologia , HIV-2/crescimento & desenvolvimento , HIV-2/imunologia , Humanos , Macaca fascicularis , Modelos Moleculares , Simulação de Dinâmica Molecular , Mutagênese Sítio-Dirigida , Conformação Proteica , Proteínas/genética , Vírus da Imunodeficiência Símia/crescimento & desenvolvimento , Vírus da Imunodeficiência Símia/imunologia , Ubiquitina-Proteína Ligases , Replicação ViralRESUMO
A series of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues were synthesized by the reaction of 5,6-dimethoxy-2-[(E)-1-phenylmethylidene]-1-indanone with hydroxylamine hydrochloride. The title compounds were tested for their in vitro anti-HIV activity. Among the compounds, (4g) showed a promising anti-HIV activity in the in vitro testing against IIIB and ROD strains. The IC50 of both IIIB and ROD were found to be 9.05 microM and > 125 microM, respectively.
Assuntos
Fármacos Anti-HIV/síntese química , Fármacos Anti-HIV/farmacologia , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Isoxazóis/síntese química , Isoxazóis/farmacologia , Linhagem Celular Tumoral , HIV-1/crescimento & desenvolvimento , HIV-2/crescimento & desenvolvimento , Humanos , Concentração Inibidora 50 , Testes de Sensibilidade Microbiana , Estrutura Molecular , Relação Estrutura-Atividade , Replicação Viral/efeitos dos fármacosRESUMO
OBJECTIVES: To assess changes in HIV incidence and prevalence in Caió, a rural area of Guinea-Bissau, between 1990 and 2007. DESIGN: Three cross-sectional community surveys. METHODS: In 1990, 1997, and 2007, surveys were conducted among adults. The prevalence of HIV-1 and of HIV-2 was estimated for each survey, and incidence rates were calculated for the first (1990-1997) and second period (1997-2007). RESULTS: The HIV-1 incidence was approximately 4.5/1000 person-years in the two periods, whereas the HIV-2 incidence decreased from 4.7 (95% confidence interval 3.6-6.2) in the first to 2.0 (95% confidence interval 1.4-3.0) per 1000 person-years in the second period (P < 0.001). HIV-1 prevalence rose from 0.5% in 1990 to 3.6% in 2007, and HIV-2 prevalence decreased from 8.3% in 1990 to 4.7% in 2007. HIV-1 prevalence was less than 2% in 15 to 24 year olds in all surveys and was highest (7.2%) in 2007 among 45 to 54 year olds. The HIV-2 prevalence was fivefold higher in older subjects (> or =45 yr) compared with those less than 45 years in both sexes in 2007. CONCLUSIONS: HIV-1 incidence is stable, and its prevalence is increasing, whereas HIV-2 incidence and prevalence are both declining. In contrast with what has been observed in other sub-Saharan countries, HIV-1 prevalence is lower in younger age groups than older age groups.
Assuntos
Surtos de Doenças , Infecções por HIV/epidemiologia , Infecções por HIV/virologia , HIV-1/crescimento & desenvolvimento , HIV-2/crescimento & desenvolvimento , Adolescente , Adulto , Anticorpos Antivirais/sangue , Estudos de Coortes , Estudos Transversais , DNA Viral/química , DNA Viral/genética , Feminino , Guiné-Bissau/epidemiologia , HIV-1/genética , HIV-2/genética , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Prevalência , Análise de Regressão , População Rural , Adulto JovemRESUMO
Macrophages are major targets of human immunodeficiency virus type 1 (HIV-1). We have previously shown that aggregation of activating immunoglobulin G Fc receptors (FcgammaR) by immune complexes inhibits reverse transcript accumulation and integration of HIV-1 and related lentiviruses in monocyte-derived macrophages. Here, we show that FcgammaR-mediated restriction of HIV-1 is not due to enhanced degradation of incoming viral proteins or cDNA and is associated to the induction of the cyclin-dependent kinase inhibitor p21(Cip1/WAF1) (p21). Small interfering RNA-mediated p21 knockdown rescued viral replication in FcgammaR-activated macrophages and enhanced HIV-1 infection in unstimulated macrophages by increasing reverse transcript and integrated DNA levels. p21 induction by other stimuli, such as phorbol myristate acetate and the histone deacetylase inhibitor MS-275, was also associated with preintegrative blocks of HIV-1 replication in macrophages. Binding of p21 to reverse transcription/preintegration complex-associated HIV-1 proteins was not detected in yeast two-hybrid, pulldown, or coimmunoprecipitation assays, suggesting that p21 may affect viral replication independently of a specific interaction with an HIV-1 component. Consistently, p21 silencing rescued viral replication from the FcgammaR-mediated restriction also in simian immunodeficiency virus SIV(mac)- and HIV-2-infected macrophages. Our results point to a role of p21 as an inhibitory factor of lentiviral infection in macrophages and to its implication in FcgammaR-mediated restriction.
Assuntos
Inibidor de Quinase Dependente de Ciclina p21/biossíntese , HIV-1/crescimento & desenvolvimento , Lentivirus de Primatas/crescimento & desenvolvimento , Macrófagos/imunologia , Macrófagos/virologia , Receptores de IgG/imunologia , Animais , Células Cultivadas , Inibidor de Quinase Dependente de Ciclina p21/antagonistas & inibidores , Inibidor de Quinase Dependente de Ciclina p21/genética , Técnicas de Silenciamento de Genes , HIV-1/imunologia , HIV-2/crescimento & desenvolvimento , HIV-2/imunologia , Humanos , Lentivirus de Primatas/imunologia , Primatas , Vírus da Imunodeficiência Símia/crescimento & desenvolvimento , Vírus da Imunodeficiência Símia/imunologia , Integração Viral/imunologia , Replicação Viral/imunologiaRESUMO
There are reports that not all individuals exposed to HIV-1 become infected and the possibility exists that some individuals may be completely resistant to infection with this virus. This study aims to investigate, in vitro, whether certain peripheral blood mononuclear cells (PBMCs) are completely resistant to HIV-1 and HIV-2 infection. PBMCs obtained from 130 unrelated healthy HIV-1- and HIV-2-seronegative volunteers were infected with four different isolates of HIV-1 (H995 and MN) and HIV-2 (CBL-20 and ROD) using several multiplicities of infection. Cultures were maintained for 21 d. Virus replication was measured using the viral p24 core antigen levels in the case of HIV-1, and by reverse transcriptase (RT) activity in the case of HIV-2, at 5, 14, and 21 d post-infection. Marked variations were observed among PBMCs from individual donors with regard to replication rates for HIV-1 and HIV-2. None of the PBMCs from any single donor was shown to have zero viral replication rates for all four HIV isolates tested. However, PBMCs from some individuals were shown to have either very low or very high viral replication rates when infected with one or more virus isolates. Our results clearly distinguished three groups of PBMCs with varying degrees of viral replication for both HIV-1 and HIV-2 infection in vitro: (a) those with high viral replication rates, (b) those with moderate viral replication rates, and (c) those with low viral replication rates. Our data indicate that although none of the PBMCs tested were shown to be completely resistant to in vitro HIV-1 and HIV-2 infection, partial resistance to infection was seen for some donor samples.
Assuntos
HIV-1/crescimento & desenvolvimento , HIV-2/crescimento & desenvolvimento , Leucócitos Mononucleares/virologia , Adolescente , Adulto , Células Cultivadas , Efeito Citopatogênico Viral , Feminino , Células Gigantes/virologia , Proteína do Núcleo p24 do HIV/biossíntese , Transcriptase Reversa do HIV/biossíntese , Humanos , MasculinoRESUMO
Many HIV-2-infected individuals maintain low, often undetectable, viral loads for prolonged periods. Virus and/or host factors that contribute to this high level of virus control are largely unknown. Previously we demonstrated that HIV-2 variants from long-term aviremic individuals have relatively low replication kinetics in vitro in comparison to HIV-1 variants. We hypothesized that the relatively low replication rates of HIV-2 in vitro as well as the high level of virus control in vivo might be explained by HIV-2 replication being more sensitive to inhibitory host factors like beta-chemokines or other CD8+ T cell-derived factors than HIV-1 replication. To test this we determined the effect of exogenously added beta-chemokines and healthy donor CD8+ T cells on the in vitro virus production of HIV-2 and HIV-1 variants from long-term nonprogressors (LTNPs). Contrary to expectations, HIV-2 replication was inhibited less efficiently by RANTES and MIP-1alpha than HIV-1 replication. CD8+ T cells from 8 of 12 healthy donors reduced HIV replication minimally 2-fold. Interestingly, cells from five of these donors inhibited HIV-1 but hardly affected HIV-2 replication, while the reverse was observed for cells from one donor. For HIV-1, but not HIV-2, the magnitude of the antiviral effect of CD8+ T cells correlated with their effect on RANTES levels in culture supernatants. Our findings indicate that RANTES is a more important factor of CD8+ T cell-associated anti-HIV-1 activity than it is of HIV-2 activity and that the benign clinical course of HIV-2 infection is not due to enhanced beta-chemokine sensitivity of HIV-2 variants.
Assuntos
Quimiocinas CC/imunologia , Infecções por HIV/virologia , HIV-1/imunologia , HIV-2/imunologia , Linfócitos T CD8-Positivos/imunologia , Células Cultivadas , HIV-1/genética , HIV-1/crescimento & desenvolvimento , HIV-2/genética , HIV-2/crescimento & desenvolvimento , Humanos , DNA Polimerase Dirigida por RNA/metabolismo , Carga Viral , Replicação Viral/imunologiaRESUMO
Non-natural amino acids with aromatic or heteroaromatic side chains were incorporated into tripeptides of the general structure Arg-X-Arg and tested as ligands of the HIV RNA element TAR. Some of these compounds could compete efficiently with the association of TAR and Tat and downregulated a TAR-controlled reporter gene in HeLa cells. Peptide 7, which contains a 2-pyrimidinyl-alkyl chain, also inhibited the spread of HIV-1 in cell cultures. NMR studies of 7 bound to HIV-2-TAR gave evidence for contacts in the bulge region.
Assuntos
Aminoácidos/farmacologia , Repetição Terminal Longa de HIV/efeitos dos fármacos , HIV/efeitos dos fármacos , Oligopeptídeos/farmacologia , Fragmentos de Peptídeos/antagonistas & inibidores , Produtos do Gene tat do Vírus da Imunodeficiência Humana/antagonistas & inibidores , Alcanos/química , Alcanos/farmacologia , Aminoácidos/química , Arginina/análogos & derivados , Arginina/farmacologia , Células Cultivadas , HIV/crescimento & desenvolvimento , HIV-1/efeitos dos fármacos , HIV-1/crescimento & desenvolvimento , HIV-2/efeitos dos fármacos , HIV-2/crescimento & desenvolvimento , Células HeLa , Humanos , Hidrocarbonetos Aromáticos/química , Hidrocarbonetos Aromáticos/farmacologia , Ligantes , Espectroscopia de Ressonância Magnética , Modelos Químicos , Oligopeptídeos/síntese química , Pirimidinas/química , Pirimidinas/farmacologia , RNA Viral/química , RNA Viral/metabolismoRESUMO
HIV appears to have diverged into several lineages upon multiple zoonotic introductions from the nonhuman primates. The HIV-2 and HIV-1 groups M, N, and O likely represent different cross-species transmission events. The radial evolution of group M in multiple clades or subtypes is likely due to adaptation and expansions in the human hosts. It is not well understood why HIV strains such as HIV-1 subtype C in particular or group M in general have spread disproportionately as compared to other subtypes, groups, or types, which often remained geographically constrained to local epidemics. Host genetic effects, transmission bottlenecks, social/behavioral and environmental limitations, founder effect and other viral factors could have contributed to variable spread through the human population. Even after transmission, viruses evolve at different rates during disease progression. Recent studies have explored phenotypic differences between HIV types, groups, and subtypes in attempts to explain or understand this radial evolution and expansion. This review explores some of the important aspects relating to fitness during disease progression, during global distribution of different HIV subtypes, and related to circulation of recombinant forms in the epidemic.